R.H. Bluestein & Co’s Amgen AMGN Stock Holding History

R.H. Bluestein & Co’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$293K	Hold	1,300	–	–	0.02%	246
2022 Q2	$316K	Hold	1,300	–	–	0.02%	234
2022 Q1	$314K	Hold	1,300	–	–	0.01%	280
2021 Q4	$292K	Hold	1,300	–	–	0.01%	323
2021 Q3	$276K	Hold	1,300	–	–	0.01%	341
2021 Q2	$317K	Sell	1,300 -1,000	-43%	-$246K	0.01%	318
2021 Q1	$572K	Hold	2,300	–	–	0.02%	189
2020 Q4	$529K	Buy	2,300 +200	+10%	+$46.1K	0.02%	186
2020 Q3	$534K	Buy	2,100 +1,100	+110%	+$273K	0.03%	152
2020 Q2	$236K	Hold	1,000	–	–	0.01%	287
2020 Q1	$203K	Hold	1,000	–	–	0.02%	256
2019 Q4	$241K	Buy	+1,000	New	+$220K	0.01%	310
2018 Q4	–	Sell	-2,525	Closed	-$523K	–	286
2018 Q3	$523K	Sell	2,525 -7,734	-75%	-$1.52M	0.03%	156
2018 Q2	$1.89M	Buy	10,259 +8,550	+500%	+$1.51M	0.1%	50
2018 Q1	$291K	Sell	1,709 -2,000	-54%	-$367K	0.02%	252
2017 Q4	$645K	Sell	3,709 -29,641	-89%	-$5.25M	0.03%	122
2017 Q3	$6.22M	Buy	33,350 +30,750	+1,183%	+$5.45M	0.34%	48
2017 Q2	$448K	Sell	2,600 -6,250	-71%	-$1.02M	0.03%	150
2017 Q1	$1.45M	Buy	+8,850	New	+$1.47M	0.09%	56

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

R.H. Bluestein & Co's AMGN Position: Q3 2022 in Review

R.H. Bluestein & Co held its Amgen (AMGN) position steady in Q3 2022 at 1,300 shares worth $293K. The position accounts for 0.02% of the portfolio, ranked #246.

R.H. Bluestein & Co first reported a position in AMGN in Q1 2017 and has held it in 19 quarters since. The position peaked at $6.22M in Q3 2017. 2,322 funds tracked by Wall St. Rank hold AMGN as of Q3 2022.

R.H. Bluestein & Co held 1,300 shares of Amgen worth $293K as of Q3 2022.
R.H. Bluestein & Co left its Amgen share count unchanged in Q3 2022.
Amgen made up 0.02% of R.H. Bluestein & Co's portfolio in Q3 2022, its #246 holding.
R.H. Bluestein & Co first reported a position in Amgen in Q1 2017 and has held it in 19 quarters since.
R.H. Bluestein & Co's Amgen position peaked at $6.22M in Q3 2017.
2,322 funds tracked by Wall St. Rank held Amgen as of Q3 2022.

Based on R.H. Bluestein & Co's 13F filing for Q3 2022, filed 14 Nov 2022.